Abraham Accords countries, such as Israel, the United Arab Emirates, Bahrain and others, could play a critical role in supplying the U.S. with generic drugs.
A U.S. initiative seeks to break America’s dependence on China for pharmaceuticals, particularly generic drugs, by moving manufacturing to more friendly Abraham Accord countries.
While there is across-the-board concern about the United States’ dependence on Chinese products, concern about the exposure of the U.S. pharmaceutical supply chain to China spiked after the COVID-19 epidemic in 2020.
Some estimates claim China controls as much as 80%-90% of the global supply of active pharmaceutical ingredients (API), the products in a drug responsible for its therapeutic effects.